Select Page

Precision Business Insights (PBI) in its report titled “Global Mesenchymal Stem Cells Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024” assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global mesenchymal stem cells market was valued at US$ XX Mn in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation and strategic collaborations between the markets players are expected to enhance the sales of the mesenchymal stem cells market. However, no therapeutic advancement regarding in vitro properties of stem cells, adverse effects and tedious, lengthy, and complex research studies are expected to hamper the growth of the market.

Global mesenchymal stem cells market segmented on the basis of source, application, end user, and region

For request sample:

Drug Discovery Area Dominates the Global Mesenchymal Stem Cells Market

Based on application, global mesenchymal stem cells market segmented into Injuries, Drug Discovery, Cardiovascular Infraction and Others. Among them drug discovery applications dominated the global mesenchymal stem cells market in 2018 and estimated to dominate over the forecast period owing to advanced research and development activities by the key players and research institutes, favorable government regulations for drug discovery with the help of mesenchymal stem cells are surge the market over the forecast years. However, a slow growth rate observed for the cardiovascular segment due to lack of awareness.
North America Leads the Global Mesenchymal Stem Cells Market

PBI’s global mesenchymal stem cells market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to increasing number of research activities and advancements in technologies, availability of skilled personnel and advanced research facilities and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Moreover, increasing prevalence of chronic diseases such as cancer, cardiovascular and autoimmune diseases and rising focus on development of new products and drugs are expected to drive the growth of the market. Asia Pacific region is expected to grow at a significant growth rate over the forecast years owing to the enhanced healthcare infrastructure, and presence of large patient pool.

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global mesenchymal stem cells market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, in 2017 Otsuka Pharmaceutical a subsidiary of Otsuka Holdings Co., Ltd purchased shares of TWO CELLS Company Limited at the same time, the two companies promoted efforts to collaborate further in regenerative cell therapies based on Mesenchymal Stem Cells (MSCs) for the treatment of central nervous system disorders. By this agreement, Otsuka and TWO CELLS together accelerate the efforts to develop practical applications of MSC-derived regenerative therapies.

Key player’s profiles in the report are
• Cell Applications, Inc. (USA)
• Celprogen, Inc. (USA)
• Cyagen US Inc. (USA)
• Genlantis, Inc. (USA)
• Lonza Group (Switzerland)
• Mesoblast Limited (Australia)
• MilliporeSigma (USA)
• Neuromics (USA)
• Orthofix International N.V. (Italy)
• PromoCell GmbH (Germany)

Detailed Segmentation

By Source of Isolation

o Bone Marrow
o Umbilical Cord Blood
o Peripheral Blood
o Lung Tissue
o Synovial Tissues
o Amniotic Fluids
o Adipose Tissues

By Applications

o Injuries
o Drug Discovery
o Cardiovascular Infraction
o Others

By End User

o Clinical research organizations
o Biotechnological companies,
o Medical research institutes,
o Hospitals

o North America
• U.S
• Canada
o Europe
• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
o Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific
o Latin America
• Brazil
• Mexico
• Argentina
• Venezuela
• Rest of Latin America
o Middle East and Africa (MEA)
• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

For more information:

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553
Website @